Lee H S, Oh J Y, Lee J H, Yoo C G, Lee C T, Kim Y W, Han S K, Shim Y S, Yim J J
Division of Respiratory and Critical Care Medicine, Dept of Internal Medicine and Lung Institute of Medical Research Centre, Seoul National University College of Medicine, Seoul, Republic of Korea.
Eur Respir J. 2004 Mar;23(3):452-5. doi: 10.1183/09031936.04.00087304.
Pulmonary tuberculomas are well-circumscribed masses caused by Mycobacterium tuberculosis. However, the response of tuberculomas to anti-tuberculous (TB) treatment has not been well defined as yet. The response of pulmonary tuberculomas to anti-TB treatment was retrospectively reviewed in 45 patients diagnosed between January 1997 and December 2001. The areas of pulmonary tuberculomas were estimated by calculating products of the longest and their perpendicular short diameters on chest radiographs. The response to anti-TB treatment was categorised as "decreased" (> 25% reduction in area versus its initial area), "increased" (> 251% increase) and "no change" (the remainder). The mean of treatment duration was 11.5 +/- 3.6 months. Three months after treatment, 18 patients (40.0%) were categorised as decreased, 25 (55.6%) as no change and two (4.4%) as increased. Twelve months after treatment, out of 42 patients available for chest radiographs, 32 patients (76.2%) were categorised as decreased, nine (21.4%) as no change and one patient (2.4%) as increased. At the last follow-up (mean follow-up 27.0 +/- 10.2 months), 37 patients (82.2%) were categorised as decreased. The majority of pulmonary tuberculomas were decreased by anti-tuberculosis treatment during and even after treatment, although a transient enlargement during the early period of treatment was observed infrequently.
肺结核球是由结核分枝杆菌引起的边界清晰的肿块。然而,目前肺结核球对抗结核治疗的反应尚未明确界定。对1997年1月至2001年12月期间确诊的45例患者的肺结核球对抗结核治疗的反应进行了回顾性研究。通过计算胸部X线片上最长径与其垂直短径的乘积来估计肺结核球的面积。将抗结核治疗的反应分为“缩小”(面积较初始面积缩小>25%)、“增大”(面积增大>25%)和“无变化”(其余情况)。平均治疗时间为11.5±3.6个月。治疗3个月后,18例患者(40.0%)被归类为缩小,25例(55.6%)为无变化,2例(4.4%)为增大。治疗12个月后,在42例可进行胸部X线检查的患者中,32例患者(76.2%)被归类为缩小,9例(21.4%)为无变化,1例患者(2.4%)为增大。在最后一次随访时(平均随访27.0±10.2个月),37例患者(82.2%)被归类为缩小。大多数肺结核球在治疗期间甚至治疗后通过抗结核治疗缩小,尽管在治疗早期偶尔观察到短暂增大。